300753 爱朋医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.492-3.5141.5481.198-10.369
总资产报酬率 ROA (%)-1.195-2.7881.2540.957-8.587
投入资产回报率 ROIC (%)-1.282-3.0141.3621.051-9.420

边际利润分析
销售毛利率 (%)65.49768.43968.41865.54849.427
营业利润率 (%)-9.398-7.8865.8163.308-27.277
息税前利润/营业总收入 (%)-9.929-6.8025.5243.466-27.874
净利润/营业总收入 (%)-7.907-7.8452.6982.002-23.507

收益指标分析
经营活动净收益/利润总额(%)93.916158.10124.81947.56295.031
价值变动净收益/利润总额(%)4.576-5.924-6.540-10.417-1.574
营业外收支净额/利润总额(%)12.383-3.398-10.960-1.1422.630

偿债能力分析
流动比率 (X)3.0842.5873.6493.4063.027
速动比率 (X)2.4742.2133.1502.9772.612
资产负债率 (%)15.88520.94118.02318.89021.129
带息债务/全部投入资本 (%)8.44412.8318.5417.6058.175
股东权益/带息债务 (%)1,045.006653.1931,026.7311,160.6661,066.015
股东权益/负债合计 (%)521.333370.731449.589428.757372.836
利息保障倍数 (X)-12.447-8.24619.56217.728-199.659

营运能力分析
应收账款周转天数 (天)161.810156.080136.065110.530128.810
存货周转天数 (天)208.881200.099167.109144.458141.201